4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-059310
President & CEO sold 83,334 shares at $23.57 ($1,964,182)
- President & CEO acquired 83,334 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBIN HOWARD W · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-01 | Exercise or conversion : show line 1 in the form | +83,334 | $11.34 | $945,008 | 235,838 | D |
| 2017-11-01 | Sale : show line 2 in the form | −83,334 | $23.57 | $1,964,182 | 152,504 | D |
| Open-market sales · 83,334 sh · avg $23.57 · $1,964,182 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-01 | Exercise or conversion : show line 3 in the form Stock Option | −83,334 | 166,666 | D |
Loading xslF345X03/doc4.xml…